All Stories

  1. Cardiovascular risk management through a community-based digital health stroke education platform (Love Your Brain): a multi-arm randomized controlled trial
  2. Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke: a multicentre randomised controlled trial.
  3. PERKS-International: A Randomized Controlled Trial Testing the Efficacy of an mHealth Application to Reduce Risk Factors for the Primary Prevention of Stroke
  4. Case Fatality of Subarachnoid Hemorrhage by Aneurysm Location
  5. Stroke Riskometer™ Mobile Phone Application improves Stroke Knowledge in a Randomised Controlled Trial
  6. Statistical analysis plan for Love Your Brain: a multi-arm randomised controlled trial of a stroke prevention digital platform
  7. Enablers and barriers for scaling up non-communicable disease interventions across diverse global health contexts: a qualitative study using the Consolidated Framework for Implementation Research
  8. Sex Differences in Prescription, Initiation, and Discontinuation of Secondary Prevention Medications After Stroke
  9. Chronic Disease Management to Enhance Medication Adherence Trajectories in Long‐Term Survivors of Stroke: A Population‐Based Cohort Study
  10. Preventing Stroke Research Priorities Project: An Initiative of Synergies to Prevent Stroke (STOPstroke)
  11. Management of people after stroke in 383 Victorian general practices, 2014–2018: analysis of linked stroke registry and general practice data
  12. Strengthening policy engagement when scaling up interventions targeting non-communicable diseases: insights from a qualitative study across 20 countries
  13. Determining the Optimal Methodology for Identifying Incident Stroke Deaths Using Administrative Datasets Within Australia
  14. Incidence of thrombocytopenia-associated cerebral venous sinus thrombosis: a population-based study
  15. Statistical analysis plan for the Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke randomised controlled clinical trial
  16. Comparison of the performance of cardiovascular risk prediction tools in rural India: the Rishi Valley Prospective Cohort Study
  17. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
  18. Incidence of Stroke in the Aboriginal and Non-Aboriginal Populations of Australia: A Data Linkage Study
  19. Association Between Changes in Norepinephrine Infusion Rate and Urinary Oxygen Tension After Cardiac Surgery
  20. Large Burden of Stroke Incidence in People with Cardiac Disease: A Linked Data Cohort Study
  21. Antihypertensive Medication Adherence and the Risk of Vascular Events and Falls After Stroke: A Real-World Effectiveness Study Using Linked Registry Data
  22. Usability and acceptability of the software ‘Arogya Sahyog’ to assess non-communicable diseases in rural India
  23. A mixed-methods feasibility study of a new digital health support package for people after stroke: the Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS) intervention
  24. Does a History of Cancer Influence the Effectiveness of Statins on Outcomes After Stroke?
  25. Global stroke statistics 2022
  26. Understanding of medications and associations with adherence, unmet needs, and perceived control of risk factors at two years post-stroke
  27. Mixed methods evaluation to explore participant experiences of a pilot randomized trial to facilitate self‐management of people living with stroke: Inspiring virtual enabled resources following vascular events (iVERVE)
  28. Personalized knowledge to reduce the risk of stroke (PERKS-International): Protocol for a randomized controlled trial
  29. Exploring dimensions of quality-of-life in survivors of stroke with communication disabilities – a brief report
  30. Costs of acute hospitalisation for stroke and transient ischaemic attack in Australia
  31. Absolute cardiovascular risk scores and medication use in rural India: a cross-sectional study
  32. The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature
  33. Exploring Barriers to and Enablers of the Adoption of Information and Communication Technology for the Care of Older Adults With Chronic Diseases: Scoping Review
  34. Case-Fatality and Functional Outcome after Subarachnoid Hemorrhage (SAH) in INternational STRoke oUtComes sTudy (INSTRUCT)
  35. Optimal Measures for Primary Care Physician Encounters after Stroke and Association with Survival: A Data Linkage Study
  36. Co-Designing a New Yoga-Based Mindfulness Intervention for Survivors of Stroke: A Formative Evaluation
  37. Treatment with Multiple Therapeutic Classes of Medication Is Associated with Survival after Stroke
  38. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study
  39. Quality of Care and One-Year Outcomes in Patients with Diabetes Hospitalised for Stroke or TIA: A Linked Registry Study
  40. Association of hypertension with infection and inflammation in a setting of disadvantage in rural India
  41. Utility of the Hospital Frailty Risk Score Derived From Administrative Data and the Association With Stroke Outcomes
  42. Intraoperative renal hypoxia and risk of cardiac surgery‐associated acute kidney injury
  43. Perspectives on rehabilitation for Aboriginal people with stroke: a qualitative study
  44. Protocol of a randomized controlled trial investigating the effectiveness of Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS)
  45. The state of stroke services across the globe: Report of World Stroke Organization–World Health Organization surveys
  46. Exploring Barriers to and Enablers of the Adoption of Information and Communication Technology for the Care of Older Adults With Chronic Diseases: Scoping Review (Preprint)
  47. Fatal and non-fatal events within 14 days after early, intensive mobilization post stroke
  48. A longitudinal examination of the frequency and correlates of self-reported neurobehavioural disability following stroke
  49. Patterns of use and discontinuation of secondary prevention medications after stroke
  50. Sex differences in quality of life after stroke were explained by patient factors, not clinical care: evidence from the Australian Stroke Clinical Registry
  51. Hospital Presentations in Long-Term Survivors of Stroke
  52. Stroke incidence and subtypes in Aboriginal people in remote Australia: a healthcare network population-based study
  53. Hospital admissions prior to primary intracerebral haemorrhage and relevant factors associated with survival
  54. Assuming one dose per day yields a similar estimate of medication adherence in patients with stroke: An exploratory analysis using linked registry data
  55. Sex differences in aneurysmal subarachnoid haemorrhage (aSAH): aneurysm characteristics, neurological complications, and outcome
  56. Continuum of care approach for managing non-communicable diseases in low- and middle-income countries
  57. Hypertension in Rural India: The Contribution of Socioeconomic Position
  58. Incidence and risk factors for stroke following percutaneous coronary intervention
  59. Global Stroke Statistics 2019
  60. Factors Associated With 90-Day Readmission After Stroke or Transient Ischemic Attack
  61. Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: A cluster randomised controlled trial
  62. Disparities in Antihypertensive Prescribing After Stroke
  63. Sex differences in risk factors for aneurysmal subarachnoid haemorrhage: Systematic review and meta-analysis
  64. Measuring stroke and transient ischemic attack burden in New Zealand: Protocol for the fifth Auckland Regional Community Stroke Study (ARCOS V)
  65. Blood Pressure, Aortic Stiffness, Hemodynamics, and Cognition in Twin Pairs Discordant for Type 2 Diabetes
  66. Sex Differences in Long-Term Quality of Life Among Survivors After Stroke in the INSTRUCT
  67. Protocol for evaluation of enhanced models of primary care in the management of stroke and other chronic disease (PRECISE)
  68. Early mobilization and quality of life after stroke
  69. Process evaluation in the field: global learnings from seven implementation research hypertension projects in low-and middle-income countries
  70. Prevalence of diabetes and pre-diabetes in rural Tehri Garhwal, India: influence of diagnostic method
  71. Factors that confound the prediction of renal medullary oxygenation and risk of acute kidney injury from measurement of bladder urine oxygen tension
  72. Multicenter, Prospective, Controlled, Before-and-After, Quality Improvement Study (Stroke123) of Acute Stroke Care
  73. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  74. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  75. Promising Use of Big Data to Increase the Efficiency and Comprehensiveness of Stroke Outcomes Research
  76. Sex Differences in Care and Long-Term Mortality After Stroke: Australian Stroke Clinical Registry
  77. The role of context in implementation research for non-communicable diseases: Answering the ‘how-to’ dilemma
  78. Age, sex, and setting in the etiology of stroke study (ASSESS): Study design and protocol
  79. Evaluating recruitment strategies for AUSPICE , a large Australian community‐based randomised controlled trial
  80. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  81. Outcomes for Patients With In-Hospital Stroke: A Multicenter Study From the Australian Stroke Clinical Registry (AuSCR)
  82. Knowledge of risk factors for hypertension in a rural Indian population
  83. Stroke Severity Versus Dysphagia Screen as Driver for Post-stroke Pneumonia
  84. Sex Differences in Severity of Stroke in the INSTRUCT Study: a Meta‐Analysis of Individual Participant Data
  85. Large expert-curated database for benchmarking document
  86. A Promising Skills-Based Intervention to Reduce Blood Pressure in Individuals With Stroke and Transient Ischemic Attack
  87. Socioeconomic Status and Long-Term Stroke Mortality, Recurrence and Disability in Iran: The Mashhad Stroke Incidence Study
  88. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
  89. Maximising data value and avoiding data waste: a validation study in stroke research
  90. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  91. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  92. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  93. Department of Error
  94. Task-shifting for cardiovascular risk factor management: lessons from the Global Alliance for Chronic Diseases
  95. Prevention of stroke: a global perspective
  96. Neurobehavioral disability in stroke patients during subacute inpatient rehabilitation: prevalence and biopsychosocial associations
  97. Understanding the potential for yoga and tai chi interventions to moderate risk factors for stroke – a scoping review
  98. Early Mobilization After Stroke Is Not Associated With Cognitive Outcome
  99. Long-term disability after stroke in Iran: Evidence from the Mashhad Stroke Incidence Study
  100. Factors influencing self-reported anxiety or depression following stroke or TIA using linked registry and hospital data
  101. Development of an electronic health message system to support recovery after stroke: Inspiring Virtual Enabled Resources following Vascular Events (iVERVE)
  102. Determining the feasibility and preliminary efficacy of a stroke instructional and educational DVD in a multinational context: a randomized controlled pilot study
  103. Excess stroke incidence in young Aboriginal people in South Australia: Pooled results from two population-based studies
  104. Evaluation of a training program of hypertension for accredited social health activists (ASHA) in rural India
  105. Advances in Stroke 2017
  106. Factors contributing to sex differences in functional outcomes and participation after stroke
  107. Five-Year Case Fatality Following First-Ever Stroke in the Mashhad Stroke Incidence Study: A Population-Based Study of Stroke in the Middle East
  108. Preventing stroke on the street where you live, work, and play
  109. Urinary hypoxia: an intraoperative marker of risk of cardiac surgery-associated acute kidney injury
  110. The Incidence and Characteristics of Stroke in Urban-Dwelling Iranian Women
  111. Quality of Life Is Poorer for Patients With Stroke Who Require an Interpreter
  112. Prescription of antihypertensive medication at discharge influences survival following stroke
  113. Five-Year Recurrence Rate and the Predictors Following Stroke in the Mashhad Stroke Incidence Study: A Population-Based Cohort Study of Stroke in the Middle East
  114. Self-Reported Exercise Prevalence and Determinants in the Long Term After Stroke: The North East Melbourne Stroke Incidence Study
  115. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  116. Department of Error
  117. Improving quality and outcomes of stroke care in hospitals: Protocol and statistical analysis plan for the Stroke123 implementation study
  118. Global stroke statistics: An update of mortality data from countries using a broad code of “cerebrovascular diseases”
  119. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  120. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  121. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  122. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  123. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  124. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  125. Department of Error
  126. Community-Based Intervention to Improve Cardiometabolic Targets in Patients With Stroke
  127. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial
  128. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
  129. Long-term unmet needs and associated factors in stroke or TIA survivors
  130. Effectiveness of a shared team approach between nurses and doctors for improved risk factor management in survivors of stroke: a cluster randomized controlled trial
  131. Risk-adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR)
  132. The potential health and economic impact of improving stroke care standards for Australia
  133. Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program
  134. Effectiveness of an Intervention to Improve Risk Factor Knowledge in Patients With Stroke
  135. Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries
  136. Sex Differences in Long-Term Mortality After Stroke in the INSTRUCT (INternational STRoke oUtComes sTudy)
  137. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
  138. Factors associated with awareness, treatment and control of hypertension in a disadvantaged rural Indian population
  139. Incidence, recurrence, and long-term survival of ischemic stroke subtypes: A population-based study in the Middle East
  140. Global stroke epidemiology
  141. STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease
  142. Epidemiology of Intracranial and Extracranial Large Artery Stenosis in a Population-Based Study of Stroke in the Middle East
  143. Long-Term Outcomes of Ischemic Stroke of Undetermined Mechanism: A Population-Based Prospective Cohort
  144. Strategies to Improve Stroke Care Services in Low- and Middle-Income Countries: A Systematic Review
  145. Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries
  146. Nurse-Led Intervention to Improve Knowledge of Medications in Survivors of Stroke or Transient Ischemic Attack: A Cluster Randomized Controlled Trial
  147. Neighborhood socioeconomic index and stroke incidence in a national cohort of blacks and whites
  148. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  149. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  150. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  151. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  152. Cluster randomised feasibility trial to improve the Control of Hypertension In Rural India (CHIRI): a study protocol
  153. Addressing the challenges of cross-jurisdictional data linkage between a national clinical quality registry and government-held health data
  154. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  155. Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)
  156. Maximizing Patient Recruitment and Retention in a Secondary Stroke Prevention Clinical Trial: Lessons Learned from the STAND FIRM Study
  157. The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low- and Middle-Income Countries
  158. Case-fatality and functional status three months after first-ever stroke in Vietnam
  159. Better outcomes for hospitalized patients with TIA when in stroke units
  160. The Global Burden of Anemia
  161. Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)
  162. AVERT 2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff
  163. Personalized medicine and stroke prevention: where are we?
  164. 10.1016/S0140-6736(15)60692-4
  165. Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme
  166. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
  167. Obesity Paradox versus Frailty Syndrome in First-Ever Ischemic Stroke Survivors
  168. A Risk Score to Predict Hypertension in Primary Care Settings in Rural India
  169. One-year case fatality rate following stroke in the Mashhad Stroke Incidence Study: a population-based study of stroke in Iran
  170. Authors’ Response to: Data sources for measuring the socioeconomic gradient of hypertension in rural populations of low- and middle-income countries
  171. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  172. Exploring threats to generalisability in a large international rehabilitation trial (AVERT)
  173. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial
  174. Longitudinal Relationships Between Cognitive Decline and Gait Slowing: The Tasmanian Study of Cognition and Gait
  175. New Strategy to Reduce the Global Burden of Stroke
  176. Statistical analysis plan (SAP) for Shared Team Approach between Nurses and Doctors For Improved Risk Factor Management (STANDFIRM): a randomised controlled trial
  177. Methodology of the Stroke Self-Management Rehabilitation Trial: An International, Multisite Pilot Trial
  178. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  179. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
  180. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study
  181. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013
  182. Statistical Analysis Plan (SAP) for a Very Early Rehabilitation Trial (AVERT): An International Trial to Determine the Efficacy and Safety of Commencing out of Bed Standing and Walking Training (Very Early Mobilization) within 24 h of Stroke Onset vs. ...
  183. The Stroke Riskometer™ App: Validation of a Data Collection Tool and Stroke Risk Predictor
  184. Trends Over Time in the Risk of Stroke After an Incident Transient Ischemic Attack
  185. Long-Term Costs of Stroke Using 10-Year Longitudinal Data From the North East Melbourne Stroke Incidence Study
  186. Progression of White Matter Hyperintensities of Presumed Vascular Origin Increases the Risk of Falls in Older People
  187. Rejoinder: Socioeconomic gradients and hypertension in low- and middle-income countries: a straw man and no solutions
  188. Expanding antiplatelet use for patients with stroke: The case for stroke of unknown type
  189. Geomagnetic Storms Can Trigger Stroke
  190. Do the socioeconomic and hypertension gradients in rural populations of low- and middle-income countries differ by geographical region? A systematic review and meta-analysis
  191. Adiposity has a greater impact on hypertension in lean than not-lean populations: a systematic review and meta-analysis
  192. Lower systolic blood pressure is associated with poorer survival in long-term survivors of stroke
  193. Advances in Stroke
  194. Discharge Is a Critical Time to Influence 10-Year Use of Secondary Prevention Therapies for Stroke
  195. Association between Farming and Chronic Energy Deficiency in Rural South India
  196. Estimating the annual number of strokes and the issue of imperfect data: an example from Australia
  197. Global stroke statistics
  198. Incidence of first ever stroke during Hajj ceremony
  199. Brain Structural Change and Gait Decline: A Longitudinal Population-Based Study
  200. What is Stroke Symptom Knowledge?
  201. Statin Therapy and Outcome After Ischemic Stroke
  202. The Prevalence, Impact and Economic Implications of Atrial Fibrillation in Stroke: What Progress Has Been Made?
  203. Risk Factor Management in Survivors of Stroke: A Double-Blind, Cluster-Randomized, Controlled Trial
  204. A plea for the use of systematic review methodology when writing guidelines and timely publication of guidelines
  205. Baseline Smoking Status and the Long-Term Risk of Death or Nonfatal Vascular Event in People with Stroke
  206. Comparison of Stroke Warning Sign Campaigns in Australia, England, and Canada
  207. Vascular cognitive impairment and Alzheimer’s disease: role of cerebral hypoperfusion and oxidative stress
  208. Is Stroke Incidence in Low- to Middle-Income Countries Driven by Economics?
  209. Organized Blood Pressure Control Programs to Prevent Stroke in Australia
  210. Urinary symptoms and natural history of urinary continence after first-ever stroke—a longitudinal population-based study
  211. Advances in Health Policy and Outcome 2010–2011
  212. No Evidence for an Epidemic of Stroke with the Ageing of the Population
  213. Excess Risk of Stroke in Australia's Aboriginal and Torres Strait Islander Populations
  214. Factors associated with quality of life in 7-year survivors of stroke
  215. Gender-specific effects of caste and salt on hypertension in poverty: a population-based study
  216. Very Early Mobilization After Stroke Fast-Tracks Return to Walking: Further Results From the Phase II AVERT Randomized Controlled Trial
  217. How generalisable is INTERSTROKE?
  218. Protocol and Pilot Data for Establishing the Australian Stroke Clinical Registry
  219. Missed opportunities to prevent stroke recurrence
  220. Sex differences in presentation, severity, and management of stroke in a population-based study
  221. Potential roles of high salt intake and maternal malnutrition in the development of hypertension in disadvantaged populations
  222. The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS)
  223. Systematic Review of Observational Studies
  224. Design and Methods of Population Surveys
  225. Case-Control Studies: The Importance of Design and Conduct
  226. Excessive Incidence of Stroke in Iran
  227. Stroke
  228. Estimating the Long-Term Costs Of Ischemic and Hemorrhagic Stroke for Australia
  229. Very Early Mobilisation and Complications in the First 3 Months after Stroke: Further Results from Phase II of A Very Early Rehabilitation Trial (AVERT)
  230. Incidence of Stroke Subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): Differences between Men and Women
  231. Smoking Cessation at 5 Years after Stroke in the North East Melbourne Stroke Incidence Study
  232. Teaching Courses
  233. Handicap 5 Years after Stroke in the North East Melbourne Stroke Incidence Study
  234. Individuals with first-ever clinical presentation of a lacunar infarction syndrome: Is there an increased likelihood of developing mild cognitive impairment in the first 12 months after stroke?
  235. Benefits and Challenges in Stroke Research in Developing Countries
  236. Patterns of Stroke Recurrence According to Subtype of First Stroke Event: The North East Melbourne Stroke Incidence Study (NEMESIS)
  237. Not All Stroke Units Are the Same: A Comparison of Physical Activity Patterns in Melbourne, Australia, and Trondheim, Norway
  238. Editorial
  239. A Very Early Rehabilitation Trial for Stroke (AVERT): Phase II Safety and Feasibility
  240. Estimating the Prevalence of Sleep-Disordered Breathing in Community-Based, Long-Term Stroke Survivors Using a Validated Predictive Model
  241. The effect of very early mobilisation after stroke on psychological well-being
  242. Economic Evaluation alongside a Phase II, Multi-Centre, Randomised Controlled Trial of Very Early Rehabilitation after Stroke (AVERT)
  243. Chapter 17 Stroke among women, ethnic groups, young adults, and children
  244. Risk Factors for Dementia
  245. Poverty and Stroke in India
  246. Why invest in a national public health program for stroke?
  247. The Large and Growing Burden of Stroke
  248. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
  249. Aboriginal and Torres Strait Islander Peoples and the Burden of Stroke
  250. Mobilisation ‘in Bed’ Is Not Mobilisation
  251. Vascular Cognitive Impairment
  252. Prevalence of Depression and Use of Antidepressant Medication at 5-Years Poststroke in the North East Melbourne Stroke Incidence Study
  253. Long-Term Cognitive Transitions, Rates of Cognitive Change, and Predictors of Incident Dementia in a Population-Based First-Ever Stroke Cohort
  254. A Very Early Rehabilitation Trial (AVERT)
  255. Control of Hypertension 5 Years After Stroke in the North East Melbourne Stroke Incidence Study
  256. Greater Incidence of Both Fatal and Nonfatal Strokes in Disadvantaged Areas: The Northeast Melbourne Stroke Incidence Study
  257. The validity of brief screening cognitive instruments in the diagnosis of cognitive impairment and dementia after first-ever stroke
  258. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): An Australian economic model for stroke
  259. Long-Term Outcome in the North East Melbourne Stroke Incidence Study
  260. HYPERTENSION 2020: CONFRONTING TOMORROW'S PROBLEM TODAY
  261. Cerebrovascular disease and dementia
  262. Knowledge of risk factors and warning signs of stroke
  263. Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit?
  264. Quality of Life After Stroke
  265. Progressive dementia after first-ever stroke: A community-based follow-up study
  266. Cholesterol Is Associated With Stroke, but Is Not a Risk Factor
  267. Trial Application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to Assist Priority Setting in Stroke
  268. Determinants of Handicap After Stroke
  269. Inactive and Alone: Physical Activity Within the First 14 Days of Acute Stroke Unit Care
  270. ‘Out of pocket’ costs to stroke patients during the first year after stroke – results from the North East Melbourne Stroke Incidence Study
  271. Smoking as a Crucial Independent Determinant of Stroke
  272. Lifetime Cost of Stroke Subtypes in Australia
  273. Editorial Comment—Minor Risk Factors for Intracerebral Hemorrhage: The Jury Is Still Out
  274. Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill
  275. Increased Risk of Cognitive Impairment 3 Months After Mild to Moderate First-Ever Stroke
  276. The role of blood pressure lowering before and after stroke
  277. Incidence and Outcome of Subtypes of Ischaemic Stroke: Initial Results from the North East Melbourne Stroke Incidence Study (NEMESIS)
  278. Brief Comprehensive Quality of Life Assessment After Stroke
  279. RE: "DOES TEA AFFECT CARDIOVASCULAR DISEASE? A META-ANALYSIS"
  280. Reduced frequency of high cholesterol levels among patients with intracerebral haemorrhage
  281. Informal Care for Stroke Survivors
  282. Handicap After Stroke: How Does It Relate to Disability, Perception of Recovery, and Stroke Subtype?
  283. Reduced Risk of Intracerebral Hemorrhage With Dynamic Recreational Exercise but Not With Heavy Work Activity
  284. Incidence of the Major Stroke Subtypes
  285. Inter-rater reliability of stroke sub-type classification by neurologists and nurses within a community-based stroke incidence study
  286. Hypertension and the risk of intracerebral haemorrhage: special considerations in patients with renal disease
  287. Heavy Drinking, but Not Moderate or Intermediate Drinking, Increases the Risk of Intracerebral Hemorrhage
  288. Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group.
  289. Interrater Reliability of the National Institutes of Health Stroke Scale: Rating by Neurologistsand N urses in a Community-Based Stroke Incidence Study
  290. The Risk of Intracerebral Haemorrhage with Smoking
  291. Acute Brain Infarction: Early Changes in Neurological Status
  292. Risk Factors for Cerebral Hemorrhage in the Era of Well-Controlled Hypertension
  293. Epidemiology of Intracerebral Hemorrhage
  294. Hypertension as a Risk Factor for Stroke Subtypes
  295. Smoking as a Risk Factor for Stroke